Intraday BUY SELL Signals
77 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement
Advertisement
GINX vs GSK
GINX vs GSK Comparison
Open Charts GINX vs GSK
SGI Enhanced Global Income ETF
Price$29.73
Change-$0.14 (-0.47%)
Volume$6.68K
Net Assets78.07M
GINX vs GSK Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
GINX vs. GSK commentary
Nov 20, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GINX is a Hold and GSK is a Hold.
SUMMARIES
FUNDAMENTALS RATINGS
GSK: Fundamental Ratings
GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 76 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 8 Undervalued | |
PROFIT vs RISK RATING 1..100 | 37 | |
SMR RATING 1..100 | 25 | |
PRICE GROWTH RATING 1..100 | 41 | |
P/E GROWTH RATING 1..100 | 87 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TECHNICAL ANALYSIS
Technical Analysis
| GINX | GSK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 85% | 2 days ago 47% |
| Stochastic ODDS (%) | 2 days ago 63% | 2 days ago 46% |
| Momentum ODDS (%) | 2 days ago 80% | 2 days ago 51% |
| MACD ODDS (%) | 2 days ago 84% | 2 days ago 40% |
| TrendWeek ODDS (%) | 2 days ago 66% | 2 days ago 49% |
| TrendMonth ODDS (%) | 2 days ago 85% | 2 days ago 57% |
| Advances ODDS (%) | 8 days ago 89% | 9 days ago 60% |
| Declines ODDS (%) | 2 days ago 62% | 17 days ago 50% |
| BollingerBands ODDS (%) | 2 days ago 73% | 2 days ago 47% |
| Aroon ODDS (%) | 2 days ago 81% | 2 days ago 51% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
GINX and
Correlation & Price change
A.I.dvisor tells us that GINX and FMS have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GINX and FMS's prices will move in lockstep.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To GINX | 1D Price Change % | ||
|---|---|---|---|---|
| GINX | 100% | -0.22% | ||
| FMS - GINX | 26% Poorly correlated | -0.30% | ||
| SAN - GINX | 25% Poorly correlated | -2.21% | ||
| GSK - GINX | 25% Poorly correlated | -0.34% | ||
| NVS - GINX | 24% Poorly correlated | -2.69% | ||
| SONY - GINX | 23% Poorly correlated | -1.44% | ||
More | ||||
GSK and
Correlation & Price change
A.I.dvisor indicates that over the last year, GSK has been closely correlated with NVS. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if GSK jumps, then NVS could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y